Conflicting findings of microglial activation on the development of tau pathology may be explained by several factors, including the use of different animal models of AD, which recapitulate different aspects of AD pathophysiology, or using different markers of tau pathology including soluble and fibrillar forms of tau. Here, MAPT is linked to Alzheimer disease.